Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022

SELL
$1.42 - $2.09 $31,744 - $46,721
-22,355 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$1.42 - $2.13 $1,065 - $1,597
-750 Reduced 3.25%
22,355 $45,000
Q3 2021

Oct 15, 2021

BUY
$1.42 - $2.0 $18,609 - $26,210
13,105 Added 131.05%
23,105 $39,000
Q2 2021

Jul 30, 2021

BUY
$1.21 - $1.89 $12,100 - $18,900
10,000 New
10,000 $19,000

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $304M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track This Portfolio

Track Paradigm, Strategies In Wealth Management, LLC Portfolio

Follow Paradigm, Strategies In Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm, Strategies In Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm, Strategies In Wealth Management, LLC with notifications on news.